The complaint will be centralized with a growing number of other Suboxone dental erosion lawsuits in the Northern District of Ohio, as part of a federal MDL or multidistrict litigation.
Manufacturers are accused of placing profits before the safety of the individuals suffering from opioid addiction, by introducing Suboxone strips without warning about the risk of dental erosion and tooth decay.
Plaintiff says the designer of the AGGA appliance directly approved use of the device on her teeth, despite a known high risk of dental damage and bone loss.
Risk of dental erosion from Suboxone was known to the drug maker, yet lawsuit indicates that users and medical community were not adequately warned about the potential side effects.
Kentucky man used the film strips for more than a decade to treat opioid use disorder, before learning the side effects of Suboxone were ruining his teeth.
Pennsylvania woman used the opioid addiction treatment for nine years before Suboxone tooth decay warnings were finally placed on the drug label, leaving her with extensive dental injuries and tooth damage.
Plaintiffs argue that they should be able to move forward with their AGGA lawsuits, even while the government decides whether to file criminal charges against the dental appliance manufacturers
Plaintiffs who have filed Anterior Growth Guidance Appliance lawsuits say the device is not fit for adults, and causes damage to the upper jaw and teeth.
